Cassava Sciences : Corporate Presentation – August 2023 -Today at 12:48 pm
Our Focus is Alzheimer's disease August 2023 Forward-Looking Statements & Safe...
Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Our Focus is Alzheimer's disease August 2023 Forward-Looking Statements & Safe...
Cassava Sciences, Inc. (NASDAQ:SAVA – Get Free Report) shares reached a new 52-week low on Monday . The company traded as low as $17.70 and last traded at $17.87, with a volume of 44589 shares traded. The stock had previously closed at $17.92. Wall Street Analyst Weigh In Separately, HC Wainwright reaffirmed a “buy” rating […]
During the Friday's sesion, 157 stocks hit new 52-week lows.
Cassava Sciences Stock (NASDAQ: SAVA) stock price, news, charts, stock research, profile.
Cassava Sciences, Inc. (NASDAQ: SAVA) saw its shares descend Thursday, as the clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the second quarter ended June 30, 2023. Net loss was $26.4 million, ...